Multitarget drugs: an epigenetic epiphany

Ganesan, A. ORCID: (2016) Multitarget drugs: an epigenetic epiphany. ChemMedChem, 11 (12). pp. 1227-1241. ISSN 1860-7179

[thumbnail of Accepted manuscript]
PDF (Accepted manuscript) - Accepted Version
Download (1MB) | Preview


Epigenetics refers to changes in a biological phenotype that are not due to an underlying change in genotype. In eukaryotes, epigenetics involves a set of chemical modifications of the DNA and the histone proteins in nucleosomes. These dynamic changes are carried out by enzymes and modulate protein–protein and protein–nucleic acid interactions to determine whether specific genes are expressed or silenced. Both the epigenetic enzymes and recognition domains are currently important drug discovery targets, particularly for the treatment of cancer. This review summarizes the progress of epigenetic targets that have reached a clinical stage: DNA methyltransferases, histone deacetylases, lysine methyltransferases, lysine demethylases, and bromodomains; this is followed by a comprehensive survey of multitarget drugs that have included an epigenetic target as one of their mechanisms of action.

Item Type: Article
Uncontrolled Keywords: cancer,dual inhibitors,epigenetics,histone deacetylases,multitarget drugs,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
Faculty \ School: Faculty of Science > School of Pharmacy
UEA Research Groups: Faculty of Science > Research Groups > Medicinal Chemistry (former - to 2017)
Faculty of Science > Research Groups > Chemical Biology and Medicinal Chemistry (former - to 2021)
Related URLs:
Depositing User: Pure Connector
Date Deposited: 09 May 2016 15:00
Last Modified: 21 Oct 2022 05:30
DOI: 10.1002/cmdc.201500394


Downloads per month over past year

Actions (login required)

View Item View Item